We now see more downside risk than upside potential for one of our previous large-cap stock picks. Additionally, we believe the likelihood of further gains in another stock from our mid-cap portfolio is now offset by fundamental risks and high valuation.
What makes this large-cap's stock attractive is the valuation discount of about 50% compared to the post-crisis company. The primary catalyst to closing this discount is the completion of a sale by March 2018. We believe that the gain potential for this value stock pick more than offset the risks.
The stock market seems to be again underestimating the ability of turnaround management to reverse the seemingly grim outlook of a struggling iconic company--including these recent examples to the contrary: Microsoft, Walmart and McDonald's.
These value stock opportunities have impressive financial traits: strong balance sheets, prodigious cash flows and generous payouts to shareholders. Strategically, they have powerful brands, strong negotiating leverage with grocers, impressive distribution networks and increasingly talented and fresh leadership teams.
We're sharing this complimentary copy of our full Research Report for Bioverativ (NYSE: BIVV)—20+ pages of financial analysis, investment philosophy and straightforward explanation. BIVV, our most recent closed out purchase recommendation, brought Turnaround Letter readers 95% stock profit in seven short months.
Harnessing Activists to Help Find Turnaround Stocks
Activist investors often produce attractive returns for their clients; and you can still use their influence to help your position as a turnaround investor in two ways: Buy a position in a stock with the expectation that an activist will soon follow or buy after an activist takes a stake.
While one of the many dozens of activist funds might find their way to selecting your particular stock, this approach is likely to be frustrating and unrewarding. A better approach is to buy after the activist makes their move. Once an activist takes a stake in a company, how do you evaluate whether it is worthwhile to follow on? Admittedly, this is a bit of an art... Learn how you can harness the power of activist investors to find market-beating turnaround stocks.
Turnaround Letter Stock Pick Named Top Performer of 2017
This Forbeswrite-up follows up on the recent Top Stock Tips report--naming The Turnaround Letter's Crocs recommendation the top performer of 2017: With 90% gains, CROX beat out 100 other investment ideas included in the report; and the stock continues to have value investing appeal, according to Putnam.
George notes, "We see additional upside for the stock in 2018 as management's efforts continue to bear fruit, though the gains will likely be more muted than we saw in 2017."